FDA inspection
Legacy Pharmaceuticals Switzerland GmbH: FDA inspection ending Jul 21, 2017
FDA inspection 1018900 · Voluntary Action Indicated (VAI) · Birsfelden
Key facts
| Inspection ID | 1018900 |
|---|---|
| Firm | Legacy Pharmaceuticals Switzerland GmbH |
| FEI number | 3007457560 |
| Address | Ruhrbergstrasse 21 |
| City | Birsfelden |
| Country | Switzerland |
| Fiscal year | 2017 |
| Inspection end date | Jul 21, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data